Author Question: A client with a severe, treatment-resistant mental illness has been assigned to an assertive ... (Read 55 times)

mcmcdaniel · **on:** Jul 19, 2018

A client with a severe, treatment-resistant mental illness has been assigned to an assertive community treatment (ACT) team.

An ACT treatment strategy that helps to prevent recurrent hospitalizations for mental health reasons is to meet with the client in the community setting _____ per week. a. Once
b. Two to four times
c. Five to six times
d. Seven to eight times

Question 2

A client diagnosed recently with AD is prescribed donepezil (Aricept). The client's spouse inquires, How does this work? Will this cure him? Which is the appropriate nursing response?

1. This medication delays the destruction of acetylcholine, a chemical in the brain necessary for memory processes. Although most effective in the early stages, it serves to delay, but not stop, the progression of the disease.
2. This medication encourages production of acetylcholine, a chemical in the brain necessary for memory processes. It delays the progression of the disease.
3. This medication delays the destruction of dopamine, a chemical in the brain necessary for memory processes. Although most effective in the early stages, it serves to delay, but not stop, the progression of the disease.
4. This medication encourages production of dopamine, a chemical in the brain necessary for memory processes. It delays the progression of the disease.

Mholman93 · **Reply #1 on:** Jul 19, 2018

Answer to Question 1

B
The continuous care team that meets with a client two to four times per week has been found to be effective in directing the client's treatment on a more continuous basis, resulting in greater stability for the client who is living in the community with the help of appropriate systems.

Answer to Question 2

1
Rationale: The most appropriate response by the nurse is to explain that donepezil delays the destruction of acetylcholine, a chemical in the brain necessary for memory processes. Although most effective in the early stages, it serves to delay, but not stop, the progression of the AD. Some side effects include dizziness, headache, gastrointestinal upset, and elevated transaminase.